The additive/synergistic action of DSF with other chemotherapy agents in inhibiting tumor cell growth and cytotoxicity is mediated through the enhancement of cellular oxidative stress, inhibition of P glycol-protein (P-gp) activity, and dysregulation of the NF-κB signaling pathway [8, 49, 50]. The gene discussed is PGP; the disease is neoplasm.